angioimmunoblastic
Showing 226 - 248 of 248
Lymphoma, Small Intestine Cancer, Solid Tumor Trial run by the CC (alvespimycin HCl)
Completed
- Lymphoma
- +2 more
- alvespimycin hydrochloride
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Trials Refe
Mar 14, 2012
Lung Cancer, Lymphoma, Lymphoproliferative Disorder Trial run by the CC (biological, drug, other)
Completed
- Lung Cancer
- +4 more
- bevacizumab
- +3 more
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Trials Refe
Mar 14, 2012
Brain and CNS Tumors, Breast Cancer, Kidney Cancer Trial run by the CC (carboxyamidotriazole, paclitaxel)
Completed
- Brain and Central Nervous System Tumors
- +8 more
-
Bethesda, Maryland
- +1 more
Mar 14, 2012
Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Atlanta (biological, drug, procedure)
Terminated
- Myeloproliferative Disorders
- +4 more
- anti-thymocyte globulin
- +5 more
-
Atlanta, GeorgiaBlood and Marrow Transplant Group of Georgia
Mar 19, 2012
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Cleveland (biological, drug, procedure)
Completed
- Chronic Myeloproliferative Disorders
- +7 more
- anti-thymocyte globulin
- +4 more
-
Cleveland, OhioCase Medical Center, University Hospitals Seidman Cancer Center,
Dec 7, 2011
Quality of Life in Younger Leukemia and Lymphoma Survivors
Completed
- Anxiety Disorder
- +9 more
- telephone-based intervention
- +5 more
-
Cleveland, OhioCase Medical Center, University Hospitals Seidman Cancer Center,
Aug 23, 2011
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in United States (aldesleukin, recombinant interferon alfa)
Completed
- Chronic Myeloproliferative Disorders
- +6 more
- aldesleukin
- recombinant interferon alfa
-
Newport Beach, California
- +4 more
May 10, 2011
Lymphoma, Solid Tumor Trial in Nashville (oxaliplatin, pemetrexed disodium)
Completed
- Lymphoma
- Solid Tumor
- oxaliplatin
- pemetrexed disodium
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Apr 14, 2011
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in New York (fluorouracil, leucovorin calcium, topotecan HCl)
Completed
- Chronic Myeloproliferative Disorders
- +6 more
- fluorouracil
- +2 more
-
New York, New YorkKaplan Cancer Center
Mar 25, 2011
Cancer Trial in London, Edinburgh, Glasgow (drug, other, procedure)
Unknown status
- Cancer
- ketamine hydrochloride
- +4 more
-
London, England, United Kingdom
- +2 more
May 12, 2011
Leukemia, Lymphoma, Solid Tumor Trial in Buffalo (filgrastim, amifostine trihydrate, carboplatin)
Completed
- Leukemia
- +2 more
- filgrastim
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Mar 3, 2011
Lymphoma, Lymphoproliferative Disorder, Small Intestine Cancer Trial in Buffalo (Src kinase inhibitor KX2-391, immunoenzyme
Completed
- Lymphoma
- +3 more
- Src kinase inhibitor KX2-391
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Mar 1, 2011
Anemia, Leukemia, Lymphoma Trial in Scottsdale, Rochester (biological, dietary supplement, drug, other)
Completed
- Anemia
- +6 more
- darbepoetin alfa
- +3 more
-
Scottsdale, Arizona
- +1 more
May 13, 2011
T Cell Lymphoma Trial in Shanghai (endostar and CHOP)
Unknown status
- T Cell Lymphoma
- endostar and CHOP
-
Shanghai, Shanghai, ChinaFudan University Cancer Hospital
Sep 14, 2010
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +72 more
- busulfan
- +5 more
-
Cleveland, OhioIreland Cancer Center at University Hospitals Case Medical Cente
Aug 5, 2010
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Seattle (drug, procedure, radiation)
Completed
- Chronic Myeloproliferative Disorders
- +6 more
- cyclophosphamide
- +2 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center
Mar 31, 2010
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Tucson (mAb A27.15, mAb E2.3)
Completed
- Chronic Myeloproliferative Disorders
- +6 more
- monoclonal antibody A27.15
- monoclonal antibody E2.3
-
Tucson, ArizonaArizona Cancer Center
Mar 12, 2010
GVHD, Leukemia, Lymphoma Trial in Marseille (biological, drug, procedure)
Unknown status
- Graft Versus Host Disease
- +4 more
- anti-thymocyte globulin
- +6 more
-
Marseille, FranceMarseille Institute of Cancer - Institut J. Paoli and I. Calmett
Jan 27, 2010
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in New Brunswick (tetradecanoylphorbol acetate)
Terminated
- Chronic Myeloproliferative Disorders
- +6 more
- tetradecanoylphorbol acetate
-
New Brunswick, New JerseyCancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Me
Jan 25, 2010